Respiratory Diseases

FDA Approves Triple Fixed-dose Inhaled Therapy for COPD
July 24, 2020

Approval was awarded to AstraZeneca for an inhaled, fixed-dose combination of budesonide/glycopyrrolate/formoterol fumarate.

Study: After COVID-19, Symptoms Persist for Majority of Patients
July 22, 2020

JAMA: After recovery from COVID-19, a majority of patients reported persistence of at least 1 symptom; more than half reported ≥3 symptoms.

Reducing Risk of Severe Dyspnea-related Psychological Trauma in COVID-19 Survivors
June 22, 2020

Prolonged "air hunger" induced during mechanical ventilation for severe COVID-19 infection can be eliminated by a change in standard of care, a new paper suggests.